Skip to main content
Clinical Trials/CTRI/2015/01/005349
CTRI/2015/01/005349
Completed
Phase 3

A Clinical study to evaluate efficacy and safety of Ayulax Capsule in the Management of Functional Constipation - NI

Welex Laboratories Pvt Ltd0 sites36 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- Functional Constipation
Sponsor
Welex Laboratories Pvt Ltd
Enrollment
36
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Welex Laboratories Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Subjects presenting with two or more of the following for the last 3 months with symptom onset at least 6 months prior to diagnosis
  • a. Straining during at least 25 percent of defecations
  • b. Lumpy or hard stools at least 25 percent of defecations
  • c. Sensation of incomplete evacuation at least 25 percent of defecations
  • d. Sensation of anorectal blockage at least 25 percent of defecations
  • e. Manual maneuvers to facilitate at least 25 percent of defecations
  • f. Fewer than three defecations per week
  • 2\. Subjects having stool form between 1 to 3 on the Bristol Stool Form Scale

Exclusion Criteria

  • 1\. Subjects with diagnosed colonic inertia.
  • 2\. Subjects who have recently undergone abdominal surgery
  • 3\. Subjects with history of anorectal surgery.
  • 4\. Subjects having other functional gastrointestinal disorders other than Functional constipation (i.e. IBS, Belching disorders etc.)
  • 5\. Subjects with serious uncontrolled \& diagnosed systemic ailments like HIV, DM and Tuberculosis.
  • 6\. Subjects with renal or liver dysfunction
  • 7\. Pregnant or lactating females
  • 8\. Subjects with disturbed thyroid functions

Outcomes

Primary Outcomes

Not specified

Similar Trials